Stay updated on NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The NADIM II record displays details of a phase II trial comparing neoadjuvant chemo-immunotherapy with chemotherapy for potentially resectable non-small-cell lung cancer, alongside participation criteria, study locations, investigators, and publications.
    Difference
    63%
    Check dated 2026-11-08T04:49:39.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:11:09.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It appears above the ClinicalTrials.gov error page.
    Difference
    1%
    Check dated 2026-10-25T02:11:47.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:56:38.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:37:18.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error page markup, including the HTML header and Home link.
    Difference
    0.5%
    Check dated 2026-09-27T02:34:46.000Z thumbnail image

Stay in the know with updates to NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.